Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 pseudogene 5 (TPTE2P5) is a pseudogene corresponding to the TPTE2 gene, a member of the dual-specificity phosphatase family that shares features with the tumor suppressor PTEN. Pseudogenes such as TPTE2P5 arise from duplication or mutation of protein-coding genes and generally lack protein-coding potential. There is no evidence for TPTE2P5 acting as a functional receptor, enzyme, or other drug target; nor is there evidence of clinical interventions, biomarkers, or disease associations specific to this pseudogene. The scientific literature and databases focus instead on the functional TPTE and TPTE2 genes. In summary, TPTE2P5 is a pseudogene lacking evidence of functional, biological, or therapeutic significance, is not considered a valid therapeutic target, and its inclusion in this context is likely incorrect or based on insufficient information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPTE2 pseudogene 5 (TPTE2P5).